In drug development, there is the well-known "Rule of Two Double Tens," which characterizes the industry as high investment, high risk, and high return. Capital and the capital market undoubtedly play a crucial role in driving drug development and fostering innovative growth for pharmaceutical companies. As an innovative drug development enterprise, we are well aware of this fact. Through initial refinement, we have already established an efficient research and management team, a range of mature development platforms, and an effective business model. We eagerly look forward to more investors favoring us, joining us in sharing this passionate journey of research and innovation, and enjoying high-value investment returns.